We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Predicting Age by Profiling Circulating Plasma Proteins

By LabMedica International staff writers
Posted on 16 Dec 2019
It has been shown to be possible to calculate the age of an individual by measuring levels of various proteins circulating in the blood plasma.

Aging is a predominant risk factor for several chronic diseases that limit longevity, and mechanisms that regulate aging have become increasingly recognized as potential therapeutic targets.

To evaluate biochemical factors linked to aging, investigators at Stanford University (Palo Alto, CA, USA) measured 2,925 plasma proteins from 4,263 young adults to nonagenarians (18–95 years old). More...
Some of the samples came from the LonGenity study, which had accumulated blood samples from a cohort of exceptionally long-lived Ashkenazi Jews.

The investigators measured the levels of roughly 3,000 proteins in plasma samples from each individual. Results revealed 1,379 proteins with levels that varied significantly with participants' age. By employing a new bioinformatics approach that uncovered marked non-linear alterations in the human plasma proteome with age, the investigators were able to define a reduced set of 373 proteins that was sufficient to predict participants' ages with considerable accuracy.

The investigators also discovered waves of changes in the distribution of plasma proteins in the fourth, seventh, and eighth decades of life (roughly at ages 34, 60, and 78), which reflected distinct biological pathways and revealed differential associations with the genome and proteome of age-related diseases and phenotypic traits.

"We have known for a long time that measuring certain proteins in the blood can give you information about a person's health status - lipoproteins for cardiovascular health, for example," said senior author Dr. Tony Wyss-Coray, professor of neurology and neurological sciences, at Stanford University. "But it has not been appreciated that so many different proteins' levels - roughly a third of all the ones we looked at - change markedly with advancing age."

The study was published in the December 5, 2019, online edition of the journal Nature Medicine.

Related Links:
Stanford University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.